Ikuti
Miguel Sobral
Miguel Sobral
Email yang diverifikasi di g.harvard.edu
Judul
Dikutip oleh
Dikutip oleh
Tahun
A facile approach to enhance antigen response for personalized cancer vaccination
AW Li, MC Sobral, S Badrinath, Y Choi, A Graveline, AG Stafford, ...
Nature materials 17 (6), 528-534, 2018
2222018
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ...
Nature communications 11 (1), 1-14, 2020
412020
Metabolic labeling and targeted modulation of dendritic cells
H Wang, MC Sobral, DKY Zhang, AN Cartwright, AW Li, MO Dellacherie, ...
Nature materials 19 (11), 1244-1252, 2020
392020
Strategies to enhance the distribution of nanotherapeutics in the brain
C Zhang, P Mastorakos, M Sobral, S Berry, E Song, E Nance, ...
Journal of Controlled Release 267, 232-239, 2017
192017
Clickable, acid labile immunosuppressive prodrugs for in vivo targeting
H Wang, MC Sobral, T Snyder, Y Brudno, VS Gorantla, DJ Mooney
Biomaterials science 8 (1), 266-277, 2020
112020
Establishing a Quantitative Endpoint for Transarterial Embolization From Real-Time Pressure Measurements
PC Gowda, VX Chen, MC Sobral, TL Bobrow, TG Romer, AK Palepu, ...
Journal of Medical Devices 15 (2), 2021
2021
Abstract B045: Antigen-free cancer vaccine to treat poorly immunogenic tumors
MC Sobral, H Wang, AJ Najibi, A Li, CS Verbeke, DJ Mooney
Cancer Immunology Research 7 (2 Supplement), B045-B045, 2019
2019
Abstract B119: DC-recruiting biomaterial vaccine to enhance antitumor immunity
AW Li, MO Dellacherie, M Sobral, OO Ali, J Kim, DJ Mooney
Cancer Immunology Research 7 (2 Supplement), B119-B119, 2019
2019
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–8